Purpose: To observe the effect of prophylactic intraocular pressure (IOP)-lowering medication (brinzolamide) on IOP after ranibizumab intravitreal injections (IVIs).
Materials And Methods: This prospective case-control study included 352 eyes from 352 patients (1 eye per patient) who were treated with ranibizumab intravitreal injection and divided randomly into two groups. Two hundred and three patients in control group only received the ranibizumab IVI, but 149 patients in case group received one drop of prophylactic intraocular brinzolamide preinjection. The IOP was measured by noncontact tonometer before injection, at 10, 30, 120 min and 1 day after injection in a sitting position.
Results: The mean IOP measured before injection, at 10, 30, 120 min and 1 day after injection individually were 15.79 ± 2.21 mmHg, 19.33 ± 4.86 mmHg, 16.64 ± 2.93 mmHg, 16.17 ± 3.13 mmHg, and 15.07 ± 2.55 mmHg in case group and were 15.82 ± 2.57 mmHg, 21.34 ± 5.88 mmHg, 18.17 ± 4.06 mmHg, 17.59 ± 4.42 mmHg, and15.48 ± 2.92 mmHg in control group. Comparing two groups, the mean increase on IOP was statistically significant at 10, 30, 120 min postinjection (P < 0.05).
Conclusions: IVI of ranibizumab causes a considerable short-term transient rise on IOP in most patients. The effect of prophylactic IOP-lowering medication on IOP after IVIs can be statistically significant from 10 min to 2 h after IVIs.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5168919 | PMC |
| http://dx.doi.org/10.4103/0301-4738.195006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Nd:YAG Laser Iridotomy Versus Surgical Iridectomy in Descemet Membrane Endothelial Keratoplasty: Comparison of Postoperative Outcome and Incidence of Ocular Hypertension.
Cornea
January 2025
Department of Ophthalmology, University of Düsseldorf, Germany.
Purpose: To evaluate outcome and incidence of ocular hypertension after Descemet membrane endothelial keratoplasty (DMEK) and DMEK combined with cataract surgery (triple DMEK) after Nd:YAG laser iridotomy (IO) and surgical iridectomy (IE).
Methods: This is a single-center, retrospective cohort study of patients who underwent DMEK or triple DMEK surgery at the Department of Ophthalmology, University Hospital Düsseldorf, Germany, from January 2018 to June 2020 and had received either a prophylactic preoperative IO or an intraoperative IE. Patient demographic data; best corrected visual acuity; central corneal thickness; intraocular pressure (IOP); endothelial cell density; and complications such as occurrence of early postoperative IOP elevation, macular edema, rebubbling rate, and incidence of glaucoma were analyzed.
Randomized Clinical Trial of Intraocular Pressure-Lowering Medications on Preventing Spikes in Intraocular Pressure Following Intravitreal Anti-Vascular Endothelial Growth Factor Injections.
Ophthalmol Ther
February 2025
Department of Ophthalmology, Mettapracharak (Wat Rai Khing) Hospital, 52 Moo 2 Rai Khing Sam Pran, Nakhon Pathom, 73210, Thailand.
Introduction: Intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) agents are a primary management option for retinal diseases. Acute elevation of intraocular pressure (IOP) is a complication associated with these injections that should be considered. This study investigated and compared the prophylactic effects of fixed combination anti-glaucoma medication on IOP spikes following intravitreal anti-VEGF injections.
View Article and Find Full Text PDFCystoid macular edema prophylaxis in cataract surgery: A protocol for network meta-analysis.
PLoS One
December 2024
Department of Surgery, Division of Ophthalmology, McMaster University, Hamilton, Ontario, Canada.
Objective: Cataracts are the leading cause of global preventable and treatable blindness. Cystoid macular edema (CME) is among the most common complications following cataract surgery. The development of CME impacts patients' quality of life and has economic implications for patients and healthcare systems.
View Article and Find Full Text PDFA pigment dispersion syndrome case with concave iris and ocular hypertension managed through a phakic ICL implantation.
Eur J Ophthalmol
November 2024
Instituto Universitario Fernández-Vega, Oviedo, Spain.
Introduction: A concave iris configuration is a characteristic feature of pigment dispersion syndrome (PDS). Therapeutic strategies to modify this configuration may be considered as first-line options for the treatment of ocular hypertension in PDS patients.
Case Description: A 37-year-old male patient with myopic anisometropia presented bilateral PDS with concave iris, Krukenberg's spindle and iris transillumination defect in both eyes.
Effectiveness of prophylactic capsular tension ring implantation during cataract surgery in highly myopic eyes.
J Cataract Refract Surg
October 2024
From the Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China (Hu, Qi, Cheng, He, Zhang, Zhao, Lu, Zhu); NHC Key laboratory of Myopia and Related Eye Diseases; Key laboratory of Myopia and Related Eye Diseases, Chinese Academy of Medical Sciences, Shanghai, China (Hu, Qi, Cheng, He, Zhang, Zhao, Lu, Zhu); Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China (Hu, Qi, Cheng, He, Zhang, Zhao, Lu, Zhu).
Purpose: To assess the effectiveness of prophylactic capsular tension ring (CTR) implantation during cataract surgery in highly myopic eyes.
Setting: Eye and Ear, Nose, and Throat Hospital of Fudan University, Shanghai, China.
Design: Prospective cohort study.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!